Janux Therapeutics
Janux Therapeutics develops immunotherapies that generate immune responses to prevent tumors and not affecting a patient’s healthy tissue. Janux technology targets all three stages of the anti-tumor immune response.
Last updated on
About Janux Therapeutics
Founded
2017Employees
51-250Funding / Mkt. Cap
$192MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
La JollaState
CaliforniaCountry
United StatesJanux Therapeutics
Find your buyer within Janux Therapeutics